+161.4%
SPMO vs AVAV
+24.2%
+137.2%
-20.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | AVAV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.6% | -1.7% | +3.3% | +1.8% |
| 7D | +2.0% | -2.2% | +4.2% | +2.2% |
| 30D | -0.4% | -13.9% | +13.6% | +1.0% |
| 3M | -1.9% | -29.2% | +27.3% | +1.0% |
| 6M | +25.0% | -36.1% | +61.2% | +29.4% |
| YTD | +26.0% | -40.2% | +66.2% | +29.8% |
| 1Y | +28.7% | -36.2% | +64.9% | +30.5% |
| All | +161.4% | +24.2% | +137.2% | +142.2% |
Cumulative growth
Daily Returns
Daily percentage return beside AVAV.
Daily Out/Under-Performance
Portfolio return minus AVAV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AVAV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded AVAV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling